Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

News > All

Total search results: 9826 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Pieris Pharmaceuticals, Inc.. (9/10/18). "Press Release: Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil., to its Board of Directors". Boston, MA. 2018-09-10
Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna. 2018-09-10
RSP Systems A/S. (9/10/18). "Press Release: RSP Systems Adds EUR 3.85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10.35 Million". Odense. 2018-09-10
Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. 2018-09-10
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. 2018-09-09
Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec and Celgene Enter Partnership in the Field of Targeted Protein Degradation". Hamburg. 2018-09-06
Novartis AG. (9/6/18). "Press Release: Novartis to Divest the Sandoz US Dermatology Business and Generic US Oral Solids Portfolio to Aurobindo". Basel. 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec AG Listed in MDAX". Hamburg. 2018-09-06
MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. 2018-09-06
Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-09-05
Minoryx Therapeutics S.L.. (9/5/18). "Press Release: Minoryx Therapeutics Announces Dosing of First US Patient in Phase 2/3 Clinical study of MIN-102 (ADVANCE)". Mataró, Barcelona. 2018-09-05
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
NTrans Technologies B.V.. (9/4/18). "Press Release: NTrans Technologies Receives Horizon 2020 SME Grant". 2018-09-04
Miracor Medical S.A.. (9/4/18). "Press Release: Miracor Medical Closes Final Tranche of Series D, Bringing the Round to €30M". Awans. 2018-09-04
Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. 2018-09-04
Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale). 2018-09-04
AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. 2018-09-03
Boehringer Ingelheim. (9/3/18). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Supports BeiGene in Its China NDA Submission of anti-PD-1 Antibody, Tislelizumab". Shanghai. 2018-09-03
Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. 2018-09-03
Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2018-09-03
EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels. 2018-09-03
BRAIN AG. (8/31/18). "Press Release: BRAIN AG Reports Growth for the First Nine Months of the 2017/18 Financial Year". Zwingenberg. 2018-08-31
Novartis Pharma GmbH. (8/31/18). "Pressemitteilung: Novartis und das Fraunhofer IZI geben Kooperation in der CAR-T Zelltherapie für Patienten in Europa bekannt". Leipzig & Nürnberg. 2018-08-31
Medigene AG. (8/31/18). "Press Release: Medigene Announces Change in Executive Leadership Team". Planegg. 2018-08-31
EMD Serono. (8/31/18). "Press Release: Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America". Rockland, MA. 2018-08-31
Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. 2018-08-30
BRAIN AG. (8/30/18). "Press Release: DOLCE Core Team Announces Membership Changes in Programme for Natural-based Sweeteners". Zwingenberg. 2018-08-30
Probiodrug AG. (8/30/18). "Press Release: Probiodrug Reports Financial Results for H1 2018 and Corporate Update". Halle (Saale). 2018-08-30
Alnylam Pharmaceuticals, Inc.. (8/30/18). "Press Release: Alnylam Receives Approval of Onpattro (patisiran) in Europe". Cambridge, MA. 2018-08-30
Enzymicals AG. (8/30/18). "Press Release: Enzymicals AG Extends Its Capacity in Business Development". 2018-08-30
Evotec AG. (8/30/18). "Press Release: Evotec and CHDI Foundation Extend Ongoing Collaboration to Fight Huntington’s Disease". Hamburg. 2018-08-30
EBD Group. (8/30/18). "Press Release: Global Life Sciences to Convene in Copenhagen for Europe's Largest Annual Biopharma Partnering Conference". Carlsbad, CA & Copenhagen. 2018-08-30
Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin. 2018-08-30
BMBF. (8/29/18). "Pressemitteilung: Startschuss für Agentur zur Förderung von Sprunginnovationen". 2018-08-29
Marinomed Biotech AG. (8/29/18). "Press Release: Vienna-based Biotech Company Marinomed on a Growth Path". 2018-08-29
Novartis AG. (8/29/18). "Press Release: European Commission Approves Novartis Combination Therapy Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600 Mutation-positive Melanoma". Basel. 2018-08-29
Novartis AG. (8/29/18). "Press Release: Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma". Basel. 2018-08-29
Nebula Genomics. (8/29/18). "Press Release: Nebula Genomics Raises $4.3M Seed Financing from Leading Tech and Biotech VCs". San Francisco, CA & Boston, MA. 2018-08-29
Roivant Sciences GmbH. (8/28/18). "Press Release: Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder". Basel & Irvine, CA. 2018-08-28
PhagoMed Biopharma GmbH. (8/28/18). "Press Release: Viruses against Bacteria. Development of Novel Therapeutics Boosted with Millions of Euros". Vienna. 2018-08-28
Apeiron Biologics AG. (8/28/18). "Press Release: Apeiron Expands Executive Board and Appoints Dr. Anderson Gaweco as Chief Medical and Scientific Officer (CMSO)". Vienna. 2018-08-28
Roche. (8/28/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2018-08-28
Affimed N.V.. (8/27/18). "Press Release: Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets". Heidelberg. 2018-08-27
Novartis AG. (8/27/18). "Press Release: Novartis Receives European Commission Approval of Its CAR-T Cell Therapy, Kymriah (tisagenlecleucel)". Basel. 2018-08-27
Evotec AG. (8/27/18). "Press Release: Evotec and Centogene Sign Global Strategic Partnership on Drug Discovery Projects in Rare Genetic Diseases". Hamburg & Rostock. 2018-08-27
Thermo Fisher Scientific Inc.. (8/27/18). "Press Release: Differential Ion Mobility Interface Boosts Proteomics Workflow Performance". Florence. 2018-08-27
British Heart Foundation. (8/25/18). "Press Release: £30m Global Challenge Launched to Tackle Heart and Circulatory Diseases". 2018-08-25
Eppendorf AG. (8/24/18). "Press Release: Control and Monitor up to 50 Cyclers from a Central Software Application". Hamburg. 2018-08-24
CMS. (8/24/18). "Pressemitteilung: Bruker Corporation erwirbt mit CMS Mehrheitsbeteiligung an Diagnostikunternehmen Hain Lifescience". Frankfurt a. M.. 2018-08-24
Nanion Technologies GmbH. (8/24/18). "Press Release: Nanion Technologies Opens New Office in Silicon Valley". Newark, CA. 2018-08-24
Bruker Corporation. (8/24/18). "Press Release: Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH". Billerica, MA. 2018-08-24
Bayer AG. (8/24/18). "Press Release: Bayer Secures Approval in the EU for Xarelto (rivaroxaban) for Patients with Coronary or Peripheral Artery Disease [Not intended for U.S. and UK Media]". Berlin. 2018-08-24
c-LEcta GmbH. (8/23/18). "Press Release: c-LEcta Lays Foundation for Further Growth and Closes Financing Round". Leipzig. 2018-08-23
Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel. 2018-08-23
BRAIN AG. (8/22/18). "Press Release: BRAIN AG Announces the Creation of SolasCure Ltd. to Continue Development of Aurase". Zwingenberg. 2018-08-22
Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug. 2018-08-22
Knauer Wissenschaftliche Geräte GmbH. (8/22/18). "Press Release: Easy to Use Mass Directed Purification with Single Quadrupole Mass Spectrometer". 2018-08-22
Evotec AG. (8/22/18). "Press Release: Evotec and Novo Nordisk Form Strategic Research Alliance in Diabetes and Obesity". Hamburg. 2018-08-22
GlucoMe Ltd.. (8/22/18). "Press Release: GlucoMe and Merck KGaA, Darmstadt, Germany to Collaborate on Digital Diabetes Management Project in Vietnam". Yarkona. 2018-08-22
Navamedic ASA. (8/21/18). "Press Release: Renews Multiple Key Distribution Agreements". Oslo. 2018-08-21
Medigene AG. (8/21/18). "Press Release: Medigene and Structured Immunity Announce Collaboration Aimed at Improving T Cell Receptor Development". Planegg. 2018-08-21
Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel. 2018-08-20
Genedata AG. (8/20/18). "Press Release: Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D". San Francisco, CA. 2018-08-20
Tecan Group Ltd.. (8/16/18). "Press Release: Tecan Accelerates Broad Genomics Strategy with the Acquisition of NuGen Technologies". Männedorf. 2018-08-16
Tecan Group Ltd.. (8/16/18). "Press Release: H1 2018 – Tecan Posts Strong Increase in Sales, Driven by Growth in the Partnering Business". Männedorf. 2018-08-16
Mologen AG. (8/16/18). "Press Release: Mologen and Oncologie. Global Assignment and Co-development Agreement Relating to Mologen’s Lead Compound Lefitolimod". Berlin. 2018-08-16
BioNTech AG. (8/16/18). "Press Release: BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". Mainz & New York, NY. 2018-08-16
Stratec Biomedical AG. (8/15/18). "Press Release: Stratec Reports H1 2018 Figures and Adjusts Financial Guidance". Birkenfeld. 2018-08-15
Evotec AG. (8/14/18). "Press Release: Evotec Partner Haplogen Enters into Collaboration with Bayer". Hamburg. 2018-08-14
Haplogen GmbH. (8/14/18). "Press Release: Haplogen Enters into a Collaboration with Bayer". Vienna. 2018-08-14
Artios Pharma Ltd.. (8/10/18). "Press Release: Artios Pharma Announces $84 million (£65 million) Series B Financing. Financing Round Led by New Investors Andera Partners and LSP". 2018-08-10
Evotec AG. (8/9/18). "Press Release: Evotec AG Reports First Half-year 2018 Results and Corporate Updates". Hamburg. 2018-08-09
Merck KGaA. (8/9/18). "Press Release: Merck Reports Solid Organic Performance in Q2 2018". Darmstadt. 2018-08-09
Pieris Pharmaceuticals, Inc.. (8/9/18). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA. 2018-08-09
Mologen AG. (8/9/18). "Press Release: Mologen AG with Positive Developments in the First Half of 2018. Successful Financing Measures and Continuation of Clinical Studies". 2018-08-09
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
Consilium Strategic Communications Ltd.. (8/8/18). "Press Release: Consilium – H1 2018 Update". Munich. 2018-08-08
Epigenomics AG. (8/8/18). "Press Release: Epigenomics AG Announces 2018 Second Quarter and Six Month Financial Results". Berlin & San Diego, CA. 2018-08-08
MorphoSys AG. (8/8/18). "Press Release: MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202". 2018-08-08
CRISPR Therapeutics AG. (8/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-08-07
BRAIN AG. (8/7/18). "Press Release: Frank Goebel, CFO of BRAIN AG, Has Asked the Supervisory Board for Early Termination of his Management Board Contract for Personal Reasons". Zwingenberg. 2018-08-07
Akouos. (8/7/18). "Press Release: Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing". Boston, MA. 2018-08-07
Boehringer Ingelheim. (8/6/18). "Press Release: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis". Ingelhei 2018-08-06
Eppendorf AG. (8/3/18). "Press Release: First Half Year 2018 – Eppendorf with Broadbased Growth above Market Average". Hamburg. 2018-08-03
Roche. (8/3/18). "Press Release: PRIME Designation Granted by European Medicines Agency for RG6042 for Treatment of Huntington’s Disease". Basel. 2018-08-03
Boehringer Ingelheim. (8/2/18). "Press Release: Boehringer Ingelheim Launches the Initiative In Reach Africa to Address Key Healthcare Infrastructure and Access Priorities across Africa". Ingelheim. 2018-08-02
Bruker Corporation. (8/2/18). "Press Release: Bruker Reports Second Quarter 2018 Financial Results". Billerica, MA. 2018-08-02
Boehringer Ingelheim. (8/1/18). "Press Release: Boehringer Ingelheim Achieves Modest Growth in the First Half of 2018". Ingelheim. 2018-08-01
SiO2 Medical Products, Inc.. (8/1/18). "Press Release: BioNTech and SMP to Evaluate SMP’s Next Generation Technology for BioNTech Products". Auburn, AL. 2018-08-01
MorphoSys AG. (8/1/18). "Press Release: MorphoSys AG Reports Second Quarter 2018 Financial Results". Planegg. 2018-08-01
Qiagen N.V.. (8/1/18). "Press Release: Qiagen Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Faunch of Companion Diagnostics". Hilden & Tokyo. 2018-08-01
Mologen AG. (8/1/18). "Press Release: Dr Ignacio Faus Appointed as New CEO of Mologen AG". Berlin. 2018-08-01
Evotec AG. (7/31/18). "Press Release: Evotec Repays 50% of EUR 140 M Acquisition Loan". Hamburg. 2018-07-31
Marinomed Biotech AG. (7/31/18). "Press Release: Pascal Schmidt Appointed CFO as Vienna Based Biotech Firm Marinomed Strengthens Its Management Team – Company Reports Strong Growth". Vienna. 2018-07-31
Roche. (7/31/18). "Press Release: Roche Purchases Shares in Tender Offer for FMI". Basel. 2018-07-31
Qiagen N.V.. (7/30/18). "Press Release: Qiagen and Hamilton Launch New Collaboration to Improve Pre-analytical Sample Processing for QuantiFERON-TB Gold Plus". Germantown, MD & Hilden & Reno, NV. 2018-07-30
Novartis AG. (7/30/18). "Press Release: Novartis Marks a New Era for Migraine Patients with the EU Approval of Aimovig, a First-of-its-Kind Treatment Specifically Designed for Migraine Prevention". Basel. 2018-07-30
next pagenext page 1 2 3 4 ... 97 98 99  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

» top